| Patent | Date |
|---|
Composition comprising at least one water-soluble pharmaceutically acceptable salt of elafibranor having improved intestinal absorption
Grant 11,185,520 - Laruelle , et al. November 30, 2 | 2021-11-30 |
Dual-action Elafibranor Metformin Salt For Treating Obesity Associated With Non-alcoholic Steatohepatitis (nash) And Hypertrigly
App 20200023067 - LARUELLE; Claude ; et al. | 2020-01-23 |
Composition Comprising At Least One Water-soluble Pharmaceutically Acceptable Salt Of Elafibranor Having Improved Intestinal Abs
App 20190274982 - LARUELLE; Claude ; et al. | 2019-09-12 |
Use Of Fenofibric Acid In The Treatment Of Hepatic Diseases
App 20190247343 - LARUELLE; Claude ; et al. | 2019-08-15 |
Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases
Grant 9,468,662 - Laruelle , et al. October 18, 2 | 2016-10-18 |
Use Of The Pat Nonapeptide In The Treatment And Prevention Of Neurodegenerative Diseases
App 20160074463 - LARUELLE; Claude ; et al. | 2016-03-17 |
Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases
Grant 9,192,654 - Temsamani , et al. November 24, 2 | 2015-11-24 |
Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base
Grant 9,029,390 - Breul , et al. May 12, 2 | 2015-05-12 |
Use Of The Pat Nonapeptide In Treating And Preventing Neurodegenerative Diseases
App 20130116193 - Temsamani; Jamal ; et al. | 2013-05-09 |
Oral Composition Containing An Antiplatelet Agent Of The Thienopyridine Family In The Form Of Free Base
App 20110123606 - Breul; Thierry ; et al. | 2011-05-26 |
Use Of The Pat Nanopeptide In The Treatment Of Autoimmune Diseases
App 20110098223 - Temsamani; Jamal ; et al. | 2011-04-28 |
Method for stabilising particle size distribution of powder active principle dispersed in a liquid and uses thereof
App 20040143012 - Gimet, Rene ; et al. | 2004-07-22 |
Micellar colloidal pharmaceutical composition containing a lipophilic active principle
App 20040052824 - Abou Chacra-Vernet, Marie-Line ; et al. | 2004-03-18 |
Galenic formulations fast disintegrating in the mouth and method for preparing same
Grant 6,669,957 - Laruelle , et al. December 30, 2 | 2003-12-30 |
Dispersible macrolide compounds and method for production thereof
Grant 6,605,301 - Zakarian , et al. August 12, 2 | 2003-08-12 |
Dispersible macrolide compounds and method for production thereof
App 20020061333 - Zakarian, Noel ; et al. | 2002-05-23 |
Pharmaceutical dosage formulations of fenofibrate and their applications
Grant 5,827,536 - Laruelle October 27, 1 | 1998-10-27 |
Spring impelled syringe guide with skin penetration depth adjustment
Grant 5,141,496 - Dalto , et al. August 25, 1 | 1992-08-25 |
Device for subcutaneous injection without a needle
Grant 5,074,843 - Dalto , et al. December 24, 1 | 1991-12-24 |
Symmetrical O-substituted dioximes of benzo-fused .beta.-diketocyclo-alkylenes, the processes for their preparation and their application as drugs
Grant 4,804,684 - Laruelle , et al. February 14, 1 | 1989-02-14 |
Antibacterial agents containing oxo-4-pyridine carboxylic acid derivatives
Grant 4,764,518 - Laruelle , et al. August 16, 1 | 1988-08-16 |
Galenical administration form of METOCLOPRAMIDE, method for its preparation and medicament comprising the new form
Grant 4,656,024 - Laruelle April 7, 1 | 1987-04-07 |
N-acyl derivatives of amino acids and their esters, and drugs in which they are present
Grant 4,621,088 - Laruelle , et al. November 4, 1 | 1986-11-04 |
Dipeptides of L-5-hydroxytryptophan, processes for their preparation and drugs in which they are present
Grant 4,518,587 - Laruelle , et al. May 21, 1 | 1985-05-21 |
Soluble N.sub.2 substituted derivatives of 2,4-diamino 5-benzyl pyrimidine, process for their preparation and medicaments containing them
Grant 4,415,574 - Laruelle , et al. November 15, 1 | 1983-11-15 |
| 